In contrast, TIM4 immunoreactivity in carcinoma cells showed no significant correlation with clinical outcomes.<h4>Conclusions</h4>These findings suggest that infiltration of TIM4-positive macrophages serves as a strong prognostic indicator in breast cancer and that TIM4 may represent a novel marker for tumor-promoting macrophages. This evidence concerns the gene TIMD4 and carcinoma.